Application of Aptamer-based Hybrid Molecules in Early Diagnosis and Treatment of Diabetes Mellitus: From the Concepts Towards the Future
- 11 June 2019
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Diabetes Reviews
- Vol. 15 (4) , 309-313
Abstract
Aptamers have several positive advantages that made them eminent as a potential factor in diagnosing and treating diseases such as their application in prevention and treatment of diabetes. In this opinion-based mini-review article, we aimed to investigate the DNA and RNA-based hybrid molecules specifically aptamers and had a logical conclusion as a promising future perspective in early diagnosis and treatment of diabetes.Keywords
This publication has 55 references indexed in Scilit:
- An Aptamer-siRNA Chimera Suppresses HIV-1 Viral Loads and Protects from Helper CD4 + T Cell Decline in Humanized MiceScience Translational Medicine, 2011
- Comparison of modification sites formed on human serum albumin at various stages of glycationClinica Chimica Acta, 2011
- Development of DNA aptamers using Cell-SELEXNature Protocols, 2010
- Nanoparticle-Mediated Expression of an Angiogenic Inhibitor Ameliorates Ischemia-Induced Retinal Neovascularization and Diabetes-Induced Retinal Vascular LeakageDiabetes, 2009
- The Structural and Functional Diversity of Metabolite-Binding RiboswitchesAnnual Review of Biochemistry, 2009
- Aptamer-based biosensors for the detection of HIV-1 Tat proteinBioelectrochemistry, 2005
- Molecular beacon aptamer fluoresces in the presence of Tat protein of HIV‐1Genes to Cells, 2000
- In vitro selection of aptamers: the dearth of pure reasonCurrent Opinion in Structural Biology, 1996
- Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replicationCell, 1990
- Systematic Evolution of Ligands by Exponential Enrichment: RNA Ligands to Bacteriophage T4 DNA PolymeraseScience, 1990